-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Ardent Health, Lowers Price Target to $15

Benzinga·08/11/2025 10:12:29
Listen to the news
JP Morgan analyst Benjamin Rossi maintains Ardent Health (NYSE:ARDT) with a Neutral and lowers the price target from $18 to $15.